Cartesian Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 125925000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2023-03-31) |
| Status | current |
| Entity | Cartesian Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:22:04.120658+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8a8b74ad-a69f-4b84-8ff1-3a669cf02e1e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001453687-23-000052Retrieved: 2026-08-19T14:22:04.120658+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001453687/cash-and-equivalents/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8a8b74ad-a69f-4b84-8ff1-3a669cf02e1e
History
- no predecessors — first report